Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins

Molecular and Cellular Proteomics

Volumn 11, Issue 7, 2012, Pages

  Mann, Benjamin F ^a,c   Goetz, John A ^a,c   House, Michael G ^b   Schmidt, C Max ^b   Novotny, Milos V ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c National Center for Glycomics and Glycoproteomics Bloomington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ASPARAGINE; GLYCAN; GLYCOPROTEIN; LECTIN; MANNOSE; TRIACYLGLYCEROL; AMINOSUGAR; FUCOSE; LECTIN, ALEURIA AURANTIA; POLYSACCHARIDE; TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; FUCOSYLATION; GLYCOBIOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MUCINOUS CYSTIC NEOPLASM; PANCREAS CANCER; PANCREAS CYST; PANCREAS JUICE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; AFFINITY CHROMATOGRAPHY; CHEMISTRY; CYST FLUID; CYSTADENOMA; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PATHOLOGY;

ALEURIA AURANTIA;

AGED; ALPHA-AMYLASES; AMINO SUGARS; BIOPSY, FINE-NEEDLE; CHROMATOGRAPHY, AFFINITY; CYST FLUID; CYSTADENOMA, MUCINOUS; EARLY DIAGNOSIS; FEMALE; FUCOSE; GENE EXPRESSION; GLYCOMICS; GLYCOPROTEINS; HUMANS; LECTINS; LIPASE; MALE; MIDDLE AGED; PANCREAS; PANCREATIC CYST; PANCREATIC NEOPLASMS; POLYSACCHARIDES; PROTEOMICS;

EID: 84863794084     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.015792     Document Type: Article

References (49)

1. Lee, K. S., Sekhar, A., Rofsky, N. M., and Pedrosa, I. (2010) Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am. J. Gastroenterol. 105, 2079-2084
2. Sand, J. A., Hyoty, M. K., Mattila, J., Dagorn, J. C., and Nordback, I. H. (1996) Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas. Surgery 119, 275-280 (Pubitemid 26082662)
3. Visser, B. C., Yeh, B. M., Qayyum, A., Way, L. W., McCulloch, C. E., and Coakley, F. V. (2007) Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI. AJR Am. J. Roentgenol. 189, 648-656 (Pubitemid 47328548)
4. Harsha, H. C., Kandasamy, K., Ranganathan, P., Rani, S., Ramabadran, S., Gollapudi, S., Balakrishnan, L., Dwivedi, S. B., Telikicherla, D., Selvan, L. D., Goel, R., Mathivanan, S., Marimuthu, A., Kashyap, M., Vizza, R. F., Mayer, R. J., Decaprio, J. A., Srivastava, S., Hanash, S. M., Hruban, R. H., and Pandey, A. (2009) A compendium of potential biomarkers of pancreatic cancer. PLoS Med. 6, e1000046
5. Parker, L. A., Porta, M., Lumbreras, B., López, T., Guarner, L., Hernández- Aguado, I., Carrato, A., Corominas, J. M., Rifà, J., Fernandez, E., Alguacil, J., Malats, N., and Real, F. X. (2011) Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: A prospective study in a clinically-relevant spectrum of patients. Eur. J. Epidemiol. 26, 229-236
6. Joergensen, M. T., Heegaard, N. H., and Schaffalitzky de Muckadell, O. B. (2010) Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer. Pancreas. 39, 243-247
7. Yue, T., Goldstein, I. J., Hollingsworth, M. A., Kaul, K., Brand, R. E., and Haab, B. B. (2009) The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol. Cell. Proteomics. 8, 1697-1707
8. Zhao, J., Patwa, T. H., Qiu, W., Shedden, K., Hinderer, R., Misek, D. E., Anderson, M. A., Simeone, D. M., and Lubman, D. M. (2007) Glycoprotein microarrays with multi-lectin detection: Unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J. Proteome Res. 6, 1864-1874 (Pubitemid 46814510)
9. Haab, B. B., Porter, A., Yue, T., Li, L., Scheiman, J., Anderson, M. A., Barnes, D., Schmidt, C. M., Feng, Z., and Simeone, D. M. (2010) Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann. Surg. 251, 937-945
10. Scarlett, C. J., Samra, J. S., Xue, A., Baxter, R. C., and Smith, R. C. (2007) Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry. ANZ J. Surg. 77, 648-653 (Pubitemid 47063352)
11. Ke, E., Patel, B. B., Liu, T., Li, X. M., Haluszka, O., Hoffman, J. P., Ehya, H., Young, N. A., Watson, J. C., Weinberg, D. S., Nguyen, M. T., Cohen, S. J., Meropol, N. J., Litwin, S., Tokar, J. L., and Yeung, A. T. (2009) Proteomic analyses of pancreatic cyst fluids. Pancreas 38, e33-e42
12. Cuoghi, A., Farina, A., Z'graggen, K., Dumonceau, J. M., Tomasi, A., Hochstrasser, D. F., Genevay, M., Lescuyer, P., and Frossard, J. L. (2011) Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts. J. Proteome Res. 10, 2664-2670
13. Miyoshi, E., Moriwaki, K., and Nakagawa, T. (2008) Biological function of fucosylation in cancer biology. J. Biochem. 143, 725-729 (Pubitemid 351918934)
14. Dwek, M. V., Jenks, A., and Leathem, A. J. (2010) A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia. Clin. Chim. Acta 411, 1935-1939
15. Shah, M., Telang, S., Raval, G., Shah, P., and Patel, P. S. (2008) Serum fucosylation changes in oral cancer and oral precancerous conditions: α-L-Fucosidase as a marker. Cancer 113, 336-346
16. Lin, Z., Simeone, D. M., Anderson, M. A., Brand, R. E., Xie, X., Shedden, K. A., Ruffin, M. T., and Lubman, D. M. (2011) Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J. Proteome Res. 10, 2602-2611
17. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N., and Miyoshi, E. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808 (Pubitemid 43673360)
18. Kang, P., Mechref, Y., Klouckova, I., and Novotny, M. V. (2005) Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun. Mass Spectrom. 19, 3421-3428 (Pubitemid 41691916)
19. Alley, W. R., Jr., Madera, M., Mechref, Y., and Novotny, M. V. (2010) Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: A potential methodology for cancer-biomarker discovery. Anal. Chem. 82, 5095-5106
20. Mann, B., Madera, M., Sheng, Q., Tang, H., Mechref, Y., and Novotny, M. V. (2008) ProteinQuant Suite: A bundle of automated software tools for label-free quantitative proteomics. Rapid Commun. Mass Spectrom. 22, 3823-3834
21. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214 (Pubitemid 46358868)
22. Ozaki, N., Ohmuraya, M., Hirota, M., Ida, S., Wang, J., Takamori, H., Higashiyama, S., Baba, H., and Yamamura, K. (2009) Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor. Mol. Cancer Res. 7, 1572-1581
23. Domon, B., and Costello, C. E. (1988) Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 27, 1534-1543 (Pubitemid 18077449)
24. Alley, W. R., Vasseur, J. A., Goetz, J. A., Svoboda, M., Mann, B. F., Matei, D. E., Menning, N., Hussein, A., Mechref, Y., and Novotny, M. V. (2012) N-Linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J. Proteome Res. 11, 2282-2300
25. Bhatia, V. N., Perlman, D. H., Costello, C. E., and McComb, M. E. (2009) Software tool for researching annotations of proteins: Open-source protein annotation software with data visualization. Anal. Chem. 81, 9819-9823
26. Mare, L., and Trinchera, M. (2004) Suppression of β-1, 3galactosyltransferase β3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans. Eur. J. Biochem. 271, 186-194 (Pubitemid 38122177)
27. Takahashi, S., Oda, T., Hasebe, T., Sasaki, S., Kinoshita, T., Konishi, M., Ueda, T., Nakahashi, C., Ochiai, T., and Ochiai, A. (2001) Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma. Pathobiology 69, 127-135 (Pubitemid 34212083)
28. Nakamori, S., Nishihara, S., Ikehara, Y., Nagano, H., Dono, K., Sakon, M., Narimatsu, H., and Monden, M. (1999) Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas. J. Exp. Clin. Cancer Res. 18, 425-432
29. Talar-Wojnarowska, R., Gasiorowska, A., Olakowski, M., Lekstan, A., Lampe, P., and Malecka-Panas, E. (2010) Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis. Pancreatology 10, 689-694
30. Tanaka, N., Okada, S., Ueno, H., Okusaka, T., and Ikeda, M. (2000) The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer. Pancreas 20, 378-381 (Pubitemid 30253650)
31. Cerwenka, H., Aigner, R., Quehenberger, F., Werkgartner, G., Bacher, H., Hauser, H., and Mischinger, H. J. (1997) Preoperative differential diagnosis of benign and malignant pancreatic lesions: The value of pancreatic secretory trypsin inhibitor, procarboxypeptidase B, CA19-9 and CEA. Hepatogastroenterology 44, 1117-1121 (Pubitemid 27326168)
32. Smith, R. A., Ghaneh, P., Sutton, R., Raraty, M., Campbell, F., and Neoptolemos, J. P. (2008) Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J. Gastrointest. Surg. 12, 1422-1428
33. Maisey, N. R., Norman, A. R., Hill, A., Massey, A., Oates, J., and Cunningham, D. (2005) CA19-9 as a prognostic factor in inoperable pancreatic cancer: The implication for clinical trials. Br. J. Cancer. 93, 740-743 (Pubitemid 41486431)
34. Ni, X. G., Bai, X. F., Mao, Y. L., Shao, Y. F., Wu, J. X., Shan, Y., Wang, C. F., Wang, J., Tian, Y. T., Liu, Q., Xu, D. K., and Zhao, P. (2005) The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur. J. Surg. Oncol. 31, 164-169 (Pubitemid 40214752)
35. Zubarik, R., Gordon, S. R., Lidofsky, S. D., Anderson, S. R., Pipas, J. M., Badger, G., Ganguly, E., and Vecchio, J. (2011) Screening for pancreatic cancer in a high-risk population with serum CA19-9 and targeted EUS: A feasibility study. Gastrointest. Endosc. 74, 87-95
36. Brand, R. E., Nolen, B. M., Zeh, H. J., Allen, P. J., Eloubeidi, M. A., Goldberg, M., Elton, E., Arnoletti, J. P., Christein, J. D., Vickers, S. M., Langmead, C. J., Landsittel, D. P., Whitcomb, D. C., Grizzle, W. E., and Lokshin, A. E. (2011) Serum biomarker panels for the detection of pancreatic cancer. Clin. Cancer Res. 17, 805-816
37. van der Waaij, L. A., van Dullemen, H. M., and Porte, R. J. (2005) Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: A pooled analysis. Gastrointest. Endosc. 62, 383-389
38. Barrabés, S., Pagès-Pons, L., Radcliffe, C. M., Tabarés, G., Fort, E., Royle, L., Harvey, D. J., Moenner, M., Dwek, R. A., Rudd, P. M., De Llorens, R., and Peracaula, R. (2007) Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology 17, 388-400 (Pubitemid 46432010)
39. Zenita, K., Kirihata, Y., Kitahara, A., Shigeta, K., Higuchi, K., Hirashima, K., Murachi, T., Miyake, M., Takeda, T., and Kannagi, R. (1988) Fucosylated type-2 chain polylactosamine antigens in human lung cancer. Int. J. Cancer. 41, 344-349 (Pubitemid 18080785)
40. Kannagi, R., Fukushi, Y., Tachikawa, T., Noda, A., Shin, S., Shigeta, K., Hiraiwa, N., Fukuda, Y., Inamoto, T., Hakomori, S., and et al. (1986) Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res. 46, 2619-2626 (Pubitemid 16120742)
41. Fukushi, Y., Hakomori, S., Nudelman, E., and Cochran, N. (1984) Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J. Biol. Chem. 259, 4681-4685 (Pubitemid 14131379)
42. Kyselova, Z., Mechref, Y., Kang, P., Goetz, J. A., Dobrolecki, L. E., Sledge, G. W., Schnaper, L., Hickey, R. J., Malkas, L. H., and Novotny, M. V. (2008) Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin. Chem. 54, 1166-1175 (Pubitemid 352009693)
43. Kyselova, Z., Mechref, Y., Al Bataineh, M. M., Dobrolecki, L. E., Hickey, R. J., Vinson, J., Sweeney, C. J., and Novotny, M. V. (2007) Alterations in the serum glycome due to metastatic prostate cancer. J. Proteome Res. 6, 1822-1832 (Pubitemid 46814506)
44. Banks, P. A., and Freeman, M. L. (2006) Practice guidelines in acute pancreatitis. Am. J. Gastroenterol. 101, 2379-2400 (Pubitemid 44477567)
45. Wendorf, P., Linder, D., Sziegoleit, A., and Geyer, R. (1991) Carbohydrate structure of human pancreatic elastase 1. Biochem. J. 278, 505-514
46. Szmola, R., and Sahin-Tóth, M. (2007) Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme Y. Proc. Natl. Acad. Sci. U.S.A. 104, 11227-11232 (Pubitemid 47175123)
47. Freeman, T. C., Davies, R., and Calam, J. (1990) Interactions of pancreatic secretory trypsin inhibitor in small intestinal juice: Its hydrolysis and protection by intraluminal factors. Clin. Chim. Acta 195, 27-39
48. Valmu, L., Paju, A., Lempinen, M., Kemppainen, E., and Stenman, U. H. (2006) Application of proteomic technology in identifying pancreatic secretory trypsin inhibitor variants in urine of patients with pancreatitis. Clin. Chem. 52, 73-81 (Pubitemid 43032469)
49. Stenman, U. H. (2002) Tumor-associated trypsin inhibitor. Clin. Chem. 48, 1206-1209